News search

E.g., 02/09/2026
E.g., 02/09/2026
Research
2 Sep 2026

A new analysis of the DapaTAVI trial, published in the European Journal of Heart Failure, confirms that dapagliflozin improves outcomes after TAVI regardless of cardiac function.